advertisement
Abstract #15810 Published in IGR 2-3
Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis
Foster CS; Havrlikova K; Baltatzis S; Christen WG; Merayo-Lloves JActa Ophthalmologica Scandinavica 2000; 78: 576-579
PURPOSE: The prevalence and management of glaucoma were evaluated in patients with juvenile rheumatoid arthritis (JRA)-associated iridocyclitis. METHODS: The records of 69 patients with JRA-associated iridocyclitis were reviewed. RESULTS: Twenty-nine (42%) of these patients had secondary glaucoma or ocular hypertension. Glaucoma was controlled with topical treatment in only seven of the 41 affected eyes (17%); systemic carbonic anhydrase inhibitor therapy resulted in control of another eight eyes. Surgery controlled all but one of the remainder. CONCLUSIONS: Glaucoma is a common complication of JRA-associated iridocyclitis. It results from prolonged, inadequately treated intraocular inflammation and in some instances, from steroid use. Medical and surgical therapy for the glaucoma associated with JRA-uveitis is challenging and incompletely effective. The authors suspect that a more aggressive approach to the treatment of JRA-associated uveitis, earlier in the course of the disease may reduce this vision robbing contribution to the process.
Dr. C.S. Foster, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Department of Ophthalmology, Boston, MA 02114, USA. fosters@helix.mgh.harvard.edu
Classification:
9.4.6 Glaucomas associated with inflammation, uveitis (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders)
